Amicrobe Selects Clinical Formulation for Amicidin-α PFC, Supported by Department of Defense for Prolonged Field Care of Injured Warfighters

/PRNewswire/ -- Amicrobe, Inc. develops synthetic biologics with physical and antimicrobial properties, called Amicidins. Today, the Company announced the...

Related Keywords

California ,United States ,Daniel Huang ,Amicrobe Amicidin ,Michael Bevilacqua ,Us Army Medical Research ,M Us Department Of Defense ,Infectious Diseases Research Program ,Development Command Military Infectious Diseases Research Program ,Amicrobe Inc ,Technology Enterprise Consortium ,Development Command ,Surgical Gel ,Medical Research ,Military Infectious Diseases Research Program ,Medical Technology Enterprise Consortium ,